Fig. 2From: Nomogram for customized recurrence prediction in primary non-muscle-invasive bladder cancer based on routine blood and urine parametersPredictive capacity of the nomogram was assessed by DCA. Decision curve analysis for 0.5-year (A), 1-year (B), 2-year (C) and 3-year (D) recurrence free survivalBack to article page